ArticleCell transplantation

Do all roads lead to Rome? The heterogeneity of relapsed/refractory diffuse large B-cell lymphoma patients who achieved therapies response and received autologous stem cell transplantation in the era of new targeted drugs.

Jiangtao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.